Investegate |Syncona Limited Announcements | Syncona Limited: Achilles reports Q1 2022 Financial Results
Investegate announcements from Syncona Limited, Achilles reports Q1 2022 Financial Results
Source: investegate.co.uk
📰 Tumor Archiving Program News
Tumor Archiving Program News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Tumor Archiving Program. Real-time updates on events, politics, business and more.
Achilles Therapeutics PLC: Achilles Therapeutics Reports Fourth Quarter and Year-End 2021 Financial Results and Recent Business Highlights
- Patient data from higher dose cNeT as monotherapy and cNeT in combination with checkpoint inhibitor expected in 2H 2022 - - Strong cash position of $266 million supports clinical development and
Source: finanznachrichten.de
Investegate |Syncona Limited Announcements | Syncona Limited: Achilles reports Full Year 2021 Results
Investegate announcements from Syncona Limited, Achilles reports Full Year 2021 Results
Source: investegate.co.uk
Investegate |Achilles Therapeutics PLC Announcements | Achilles Therapeutics PLC: Achilles Therapeutics Provides Business Update and Outlook for 2022
Investegate announcements from Achilles Therapeutics PLC, Achilles Therapeutics Provides Business Update and Outlook for 2022
Source: investegate.co.uk
Achilles Therapeutics PLC: Achilles Therapeutics Provides Business Update and Outlook for 2022
LONDON, Jan. 13, 2022 (GLOBE NEWSWIRE) -- Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical company developing precision T cell therapies to treat solid tumors, today announces
Source: finanznachrichten.de